6EAY

Structural Basis for Broad Neutralization of Ebolaviruses by an Antibody Targeting the Glycoprotein Fusion Loop

6EAY の概要

• エントリーDOI: 10.2210/pdb6eay/pdb
• 分子名称: CA45 light chain, CA45 heavy chain, Envelope glycoprotein, ... (6 entities in total)
• 機能のキーワード: ebolavirus, glycoprotein, cross-protective antibody, broadly neutralizing antibody, ca45, fusion loop, cross-reactive, filovirus, viral protein
• 由来する生物種: Macaca fascicularis; 詳細
• タンパク質・核酸の鎖数: 4
• 化学式量合計: 104257.06

構造登録者

Janus, B.M.,Ofek, G. (登録日: 2018-08-03, 公開日: 2018-10-10, 最終更新日: 2024-10-16)

主引用文献

Janus, B.M.,van Dyk, N.,Zhao, X.,A Howell, K.,Soto, C.,Aman, M.J.,Li, Y.,Fuerst, T.R.,Ofek, G.
Structural basis for broad neutralization of ebolaviruses by an antibody targeting the glycoprotein fusion loop.
Nat Commun, 9:3934-3934, 2018

PubMed Abstract: The severity of the 2014-2016 ebolavirus outbreak in West Africa expedited clinical development of therapeutics and vaccines though the countermeasures on hand were largely monospecific and lacked efficacy against other ebolavirus species that previously emerged. Recent studies indicate that ebolavirus glycoprotein (GP) fusion loops are targets for cross-protective antibodies. Here we report the 3.72 Å resolution crystal structure of one such cross-protective antibody, CA45, bound to the ectodomain of Ebola virus (EBOV) GP. The CA45 epitope spans multiple faces of the fusion loop stem, across both GP1 and GP2 subunits, with ~68% of residues identical across > 99.5% of known ebolavirus isolates. Extensive antibody interactions within a pan-ebolavirus small-molecule inhibitor binding cavity on GP define this cavity as a novel site of immune vulnerability. The structure elucidates broad ebolavirus neutralization through a highly conserved epitope on GP and further enables rational design and development of broadly protective vaccines and therapeutics.

PubMed: 30258051
DOI: 10.1038/s41467-018-06113-4

実験手法

X-RAY DIFFRACTION (3.72 Å)